コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e mechanochemical motions in T. thermophilus leucyl-tRNA synthetase.
2 nate amino acids that can be misactivated by leucyl-tRNA synthetase.
3 he ser-tRNACAG and preventing binding of the leucyl-tRNA synthetase.
4 le inhibiting the Mycobacterium tuberculosis leucyl-tRNA synthetase.
5 Leu is a very poor substrate for full-length Leucyl-tRNA synthetase.
6 editing of mischarged tRNA similar to other leucyl-tRNA synthetases.
7 out mischarging by glycyl-, glutaminyl-, and leucyl-tRNA synthetases.
8 use HSPE71, Rat RhoGAP protein, S cerevisiae leucyl tRNA synthetase and S cerevisiae chromosome II OR
10 y a constitutive protein complex composed of leucyl-tRNA-synthetase and folliculin, which regulates m
11 ein, different mutations in Escherichia coli leucyl-tRNA synthetase are combined to unmask the pretra
12 of onychomycosis, inhibits yeast cytoplasmic leucyl-tRNA synthetase by formation of a stable tRNA(Leu
13 he collective motion in Thermus thermophilus leucyl-tRNA synthetase by studying the low frequency nor
16 These mutations that altered or abolished leucyl-tRNA synthetase editing were introduced into comp
17 overcome this limitation, we have adapted a leucyl-tRNA synthetase from Methanobacterium thermoautot
18 n identified a mutation in the mitochondrial leucyl-tRNA synthetase gene (lrs-2) that impaired mitoch
20 d mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase: homozygous c.1565C>A (p.Thr522As
26 rving cells of leucine or treating them with leucyl-tRNA synthetase inhibitors did not elicit nuclear
27 ted that the transfer of human mitochondrial leucyl-tRNA synthetase into the cybrid cells carrying th
28 re we report the surprising observation that leucyl-tRNA synthetase (LARS) becomes repressed during m
30 er the overexpression of human mitochondrial leucyl-tRNA synthetase (LARS2) in the cytoplasmic hybrid
33 c and editing activities of Escherichia coli leucyl-tRNA synthetase (LeuRS) demonstrate that the enzy
34 rmatics analyses, we identified two distinct leucyl-tRNA synthetase (LeuRS) genes within all genomes
45 this biocontrol agent targets A. tumefaciens leucyl-tRNA synthetase (LeuRS), an essential enzyme for
47 targeting an unprecedented Wolbachia enzyme, leucyl-tRNA synthetase (LeuRS), effectively inhibiting i
48 n-based compounds (benzoxaboroles) targeting leucyl-tRNA synthetase (LeuRS), including an antibiotic
51 a unique tRNA-dependent mechanism to inhibit leucyl-tRNA synthetase (LeuRS), while the TM84-producer
56 cluding a complex between prolyl-(ProRS) and leucyl-tRNA synthetases (LeuRS) in Methanothermobacter t
62 ulting from cancer-associated MTOR mutations.Leucyl-tRNA synthetase (LRS) is a leucine sensor of the
65 carboxy-terminal domain (Cterm) of human mt-leucyl tRNA synthetase rescues the pathologic phenotype
66 cid editing active site for Escherichia coli leucyl-tRNA synthetase resides within the CP1 domain tha
67 hreonine-rich region of the Escherichia coli leucyl-tRNA synthetase's CP1 domain that is hypothesized
68 tational analysis within yeast mitochondrial leucyl-tRNA synthetase showed that the enzyme has mainta
70 roach exploits an engineered E. coli-derived leucyl tRNA synthetase-tRNA pair that incorporates a pho
71 ed conformational changes of T. thermophilus leucyl-tRNA synthetase upon substrate binding and analyz
72 red the refolding of the human mitochondrial leucyl-tRNA synthetase variant H324Q to that of wild typ
73 be aminoacylated by the human mitochondrial leucyl-tRNA synthetase, we examined the aminoacylation k